tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Archer Materials Advances Quantum and Biochip Technologies

Story Highlights
  • Archer Materials progresses in quantum technology with improved qubit capabilities.
  • Biochip advancements target chronic kidney disease, enhancing scalability and performance.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Archer Materials Advances Quantum and Biochip Technologies

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An announcement from Archer Materials ( (AU:AXE) ) is now available.

Archer Materials has made significant progress in its 12CQ quantum project by demonstrating the Coulomb blockade phenomenon and improving spin coherence times, moving closer to achieving a functional qubit. The company is also advancing its Biochip platform with successful CMOS integration and biosensor enhancements, targeting applications in chronic kidney disease. These developments, along with strategic leadership changes and a strong financial position, underscore Archer’s commitment to innovation and commercialisation.

The most recent analyst rating on (AU:AXE) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Archer Materials stock, see the AU:AXE Stock Forecast page.

More about Archer Materials

Archer Materials Limited is a semiconductor company focused on advancing the quantum technology and medical diagnostics industries.

Average Trading Volume: 290,692

Technical Sentiment Signal: Sell

Current Market Cap: A$68.81M

Learn more about AXE stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1